GlaxoSmithKline plc must pay $3 billion in the largest health care fraud settlement in U.S. history, underscoring that companies expose themselves to the risk of denting shareholder value by breaking the law. Moreover, the price tag for getting caught is tough for investors to predict. Regulators alleged that the U.K. pharmaceutical manufacturer marketed the drugs [...]